TILT BIOTHERAPEUTICS OY -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 2
Sole participant: 2
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 2.100.000 0 2.100.000 1
2019 0 2.924.526 280.806 1
2018 1.770.125 0 1.770.125 1
2015 0 1.304.414 538.291 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACCELOPMENT SCHWEIZ1
AVECTAS LIMITED1
BECTON DICKINSON RESEARCH CENTRE IRELAND LIMITED1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
COBRA BIOPHARMA MATFORS AB1
HORIZON DISCOVERY LIMITED1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA1
KUNGLIGA TEKNISKA HOEGSKOLAN1
MEIRAGTX UK II1
NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED1
ORCA THERAPEUTICS BV1
SPIBER TECHNOLOGIES AB1
STICHTING VU1
STICHTING VUMC1
TECHNISCHE UNIVERSITAET DARMSTADT1
UNIVERSIDADE NOVA DE LISBOA1
UNIVERSITY COLLEGE DUBLIN1
UNIVERSITY OF HELSINKI1

Constancy:

Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-07-01Fighting cancer with next generation oncolytic immunotherapy in ovarian, head & neck, and lung cancers (Immune Checkpoint Response Enabling Adenovirus Technology ) I-CREATEcoordinator2.100.0001
2019-01-01European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis STACCATOparticipant2.924.52616
2018-07-01Unleashing the curative potential of cancer immunotherapy UNLEASHADcoordinator1.770.1251
2015-10-01Viruses, Immune stimulation and RNA Interference in Oncology Network VIRIONparticipant1.304.4144